[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain

Eur J Pharmacol. 1990 Nov 27;191(2):239-43. doi: 10.1016/0014-2999(90)94155-q.

Abstract

[3H]Nisoxetine binds with high affinity (Kd = 0.7 nM) and selectivity to a homogenous population of sites associated with the uptake of norepinephrine. Specific [3H]nisoxetine binding to rat cortical homogenates was saturable, sodium-dependent and averaged 90% of total binding at its Kd concentration. Pretreatment with the neurotoxin DSP-4 resulted in 95% decrease in binding. [3H]Nisoxetine exhibits superior properties to radioligands previously used and appears to be the radioligand of choice for studies involving uptake sites for norepinephrine.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzylamines / pharmacology
  • Cerebral Cortex / metabolism*
  • Fluoxetine / analogs & derivatives*
  • Fluoxetine / pharmacokinetics
  • Male
  • Norepinephrine / metabolism*
  • Premedication
  • Radioligand Assay
  • Rats
  • Rats, Inbred Strains

Substances

  • Benzylamines
  • Fluoxetine
  • nisoxetine
  • DSP 4
  • Norepinephrine